Unicycive Therapeutics (UNCY) PT Lowered to $23 at Brookline Capital Markets

April 7, 2026 4:31 PM

Brookline Capital Markets analyst Kumaraguru Raja lowered the price target on Unicycive Therapeutics (NASDAQ: UNCY) to $23.00 (from $40.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found